DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies

DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies

Bibliographic Details
Main Authors:	Fuchs JD, Morgan C, Bart P, Kochar N, Frahm N, Swann E, Gilbert P, DeRosa S, Graham B, Nabel G, Liao H, Haynes B, Tomaras G
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
by: Alexander J, et al.
Published: (2012-09-01)

An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies.
by: Saikat Boliar, et al.
Published: (2015-01-01)

Analysis of Cross-Clade Neutralizing Antibodies against HIV-1 Env Induced by Immunofocusing
by: Kaiser, Fabian Marc Philipp
Published: (2012)

Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C.
by: Jeff Alexander, et al.
Published: (2013-01-01)

Serotyping HIV-1 with V3 peptides: detection of high avidity antibodies presenting clade-specific reactivity
by: J. Casseb, et al.
Published: (2002-03-01)

Recombinant Env proteins that bind the quaternary-specific, V1/V2-directed PGT antibodies
by: Gorman J, et al.
Published: (2012-09-01)

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
by: Liao L, et al.
Published: (2012-09-01)

Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer.
by: Rajesh Kumar, et al.
Published: (2021-04-01)

Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses
by: Hulot SL, et al.
Published: (2012-09-01)

Similarity of Chemokines Charge and the V3 Domain of HIV-1 env Protein
by: Ben Berkhout, et al.
Published: (1998-06-01)

SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys
by: Siddappa Nagadenahalli B, et al.
Published: (2008-10-01)

Serological and Pathogenic Analyses of Fowl Adenovirus Serotype 4 (FAdV-4) Strain in Muscovy Ducks
by: Xianglong Yu, et al.
Published: (2018-06-01)

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.
by: Gerard Zurawski, et al.
Published: (2016-01-01)

An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV.
by: Jennifer D Watkins, et al.
Published: (2011-03-01)

Key Positions of HIV-1 Env and Signatures of Vaccine Efficacy Show Gradual Reduction of Population Founder Effects at the Clade and Regional Levels
by: Changze Han, et al.
Published: (2020-06-01)

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial
by: Williams WB, et al.
Published: (2012-09-01)

R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models.
by: Nagadenahalli B Siddappa, et al.
Published: (2010-07-01)

Oral priming with replicating adenovirus serotype 4 followed by subunit H5N1 vaccine boost promotes antibody affinity maturation and expands H5N1 cross-clade neutralization.
by: Surender Khurana, et al.
Published: (2015-01-01)

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
by: Heyndrickx L, et al.
Published: (2012-09-01)

Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
by: Rebekah Sherburn, et al.
Published: (2021-08-01)

Distinct evolutionary trajectories of V1R clades across mouse species
by: Caitlin H. Miller, et al.
Published: (2020-08-01)

Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies
by: Cheng Zhu, et al.
Published: (2019-02-01)

Serotypes of Adenovirus and the incidence study in mid-Taiwan
by: Hsing-Fen wei, et al.
Published: (2003)

Isolation of a novel monkey adenovirus reveals a new phylogenetic clade in the evolutionary history of simian adenoviruses
by: Bofill-Mas Silvia, et al.
Published: (2011-03-01)

Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon.
by: Xiaobo Su, et al.
Published: (2016-01-01)

Virucidal effect of commercial disinfectants on fowl adenovirus serotype 1 strains causing chicken gizzard erosion in Japan
by: D. Inoue, et al.
Published: (2020-06-01)

Development of Vaccine Against Fowl Adenovirus serotype 4
by: Tsai, Tsun-En, et al.
Published: (2018)

Plastic bronchitis associated with adenovirus serotype 7 in children
by: Lin Yuan, et al.
Published: (2020-06-01)

Serotype Chimeric Human Adenoviruses for Cancer GeneTherapy
by: Akseli Hemminki, et al.
Published: (2010-09-01)

Structural Basis for Env Incorporation into HIV-1 Particles
by: R. Elliot Murphy, et al.
Published: (2020-07-01)

Equine keratitis and the possible involvement of equine adenovirus type 1 (EAdV1) and type 2 (EAdV2)
by: McMullen Jr., Richard Joseph
Published: (2005)

Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys
by: Brandon F. Keele, et al.
Published: (2017-06-01)

Study of immunobiological properties of avian adenovirus serotype 2-based vaccine against adenovirus infection
by: A. A. Perepecha, et al.
Published: (2018-04-01)

Structure and Dynamics of HIV-1 Env Trimer
by: Wang, Haoqing
Published: (2019)

Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.
by: Andrew W Harmon, et al.
Published: (2018-01-01)

Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012).
by: Michelle C Crank, et al.
Published: (2016-01-01)

Detection of Latent HIV-1 Infection and Drug Resistant Mutation Testing in Nepal: HIV-1 env V3 DNA Sequence and RT Gene (M184V) Mutation
by: Rupendra Shrestha, et al.
Published: (2016-12-01)

T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizations.
by: Daniela C Mónaco, et al.
Published: (2011-01-01)

Frequency of adenovirus serotype 8 in patients with Keratoconjunctivitis, in Ahvaz, Iran
by: Kolsoom Shafiei, et al.
Published: (2019-05-01)

Adenovirus Serotype 14 Infection, New Brunswick, Canada, 2011
by: Gabriel Girouard, et al.
Published: (2013-01-01)

Cannot write session to /tmp/vufind_sessions/sess_dg9fu0v46tvil03u9j7427p1s2